Our Nature Medicine paper received Clinical Publication of the Year award. This combination typhoid and non-typhoidal Salmonella vaccine is an invention of CVD investigators.
13
Wilbur Chen retweeted
First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122
✅ Just Accepted
✍️ @wilburchenmd
🔗 bit.ly/42kOtRv
Check out Dr. Justin Ortiz's publication on a Lassa fever vaccine, hitchhiking on a rabies vaccine. Kudos to the scientists at the Center for Vaccine Development and Global Health and at Sidney Kimmel Medical College. nature.com/articles/s41591-0…
20
Huge congrats to Likak Research on 15 years of supporting clinical research in West and Central Africa! Honored by their "Outstanding Partner" award, but Likak is the real MVP.
8
The CVD's own combined typhoid and non-typhoidal Salmonella vaccine was evaluated in a second trial and recently published in The Journal of Infectious Diseases.
academic.oup.com/jid/article…
10
The CVD's own combined Shigella-ETEC vaccine was evaluated in a Phase 1 study and recently published in The Journal of Infectious Diseases (Editor's Choice).
academic.oup.com/jid/article…
9
Last week the NmCV-5 EPI Study Team received the 2026 Best Publication Award from the NIAID-supported IDCRC for our publication in The Lancet last year. I want to highlight how this award confirms the excellence of my colleagues @CVDMali @ProfessorSow.
thelancet.com/journals/lance…
10
This article represents the first look at the safety and robust immunogenicity of our combined typhoid and non-typhoidal Salmonella vaccine.
nature.com/articles/s41591-0…
Listen to my discussion with Ed Butch on advice regarding health essentials for international travel with study abroad experiences.
From Campus to Global Classroom: Health Essentials for Study Abroad - On Campus Podcast
24
Listening to "A Conversation With Dr. Wilbur Chen on Federally Funded Research and Global Health" at buzzsprout.com/1810727/episo…
Listen to Research Ethics Reimagined, Human Challenge Studies.
podcasts.apple.com/us/podcas…
2
30
I am honored to continue to advocate for the value of vaccines through NFID. I am looking forward to working with terrific colleagues who are like-minded in protecting the public.
NFID Announces 2025-2026 Board of Directors
Our Center’s very own, Dr Justin Ortiz, is leading this important study.
niaid.nih.gov/news-events/ni…
Listening to "A Conversation With Dr. Wilbur Chen on Federally Funded Research and Global Health" at buzzsprout.com/1810727/episo…
29
Check out our publication on Shigella bacteriophage.
Antibiotics | Free Full-Text | Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial (mdpi.com)
1
54
NIH selects Dr. Kathleen Neuzil as director of the Fogarty International Center and NIH associate director for international research






